Clinical outcomes following androgen receptor axis therapies (ARAT) among men with prostate cancer (PCa) having major cardiovascular diseases (CVDs) or extreme polypharmacy (EPP): A population based study.

Authors

• William Kelly

Publication/Presentation Date

6-2018

Volume

36

Issue

15

Published In/Presented At

DOI: 10.1200/JCO.2018.36.15_suppl.5056

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

Department(s)

Administration and Leadership

Document Type

Article